EXHIBIT 99.1 Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2026 and updated its full year guidance for the year ending December 31, 2026. Second Quarter 2026 Financial Highlights & Key Metrics See "Non-GAAP Financial Measures" ...